论文部分内容阅读
目的:探究卡培他滨联合奥沙利铂治疗胃癌的效果。方法:选取2011年2月到2013年1月入住我院的138例经胃镜病理学检查确诊的胃癌患者,随机均分两组,对照组和观察组;给予对照组的患者D2根治术的治疗方案,给以观察组的患者D2根治术配合卡培他滨联合奥沙利铂化疗的治疗方案,对比分析两组患者治疗后的临床疗效。结果:术后观察组患者有效率(59.4%)明显高于对照组的有效率(31.8%),且两组差异显著(P<0.05)。结论:卡培他滨联合奥沙利铂的治疗胃癌临床疗效得到大大的提高,是治疗胃癌的有效方法,值得临床上进行推广。
Objective: To investigate the effect of capecitabine combined with oxaliplatin on gastric cancer. Methods: A total of 138 gastric cancer patients diagnosed by gastroscopic pathology admitted to our hospital from February 2011 to January 2013 were randomly divided into two groups: control group and observation group. Patients in control group were treated with D2 radical mastectomy Program to give the observation group of patients with D2 radical mastectomy combined with capecitabine combined with oxaliplatin chemotherapy, comparative analysis of two groups of patients after treatment of clinical efficacy. Results: The effective rate of postoperative observation group (59.4%) was significantly higher than that of control group (31.8%), and the difference between the two groups was significant (P <0.05). Conclusion: The curative effect of capecitabine combined with oxaliplatin in the treatment of gastric cancer has been greatly improved. It is an effective method to treat gastric cancer and is worth to be popularized clinically.